Subtype
Kidney and Ureter Neoplasm
CI-CAN-00001051Explore in graph →
Non-malignant518 active trials17 approved drugs81 evidence items
- NCIt
- C7514
Loading cancer entity…
Subtype
CI-CAN-00001051Explore in graph →
Clinical trials
2,410 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02966509 | Engagement of Patients With Advanced Cancer(EPAC) | completed | N/A | 213 | Stanford UniversityOTHER | 0 | Oct 31, 2018 | clinicaltrials |
| NCT00896454 | Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium | completed | Phase 2 | 33 | AmgenINDUSTRY | 5 | Oct 17, 2018 | clinicaltrials |
| NCT01606787 |
| Mannitol Use During Partial Nephrectomy Prior to Renal Ischemia and Impact on Renal Function Outcomes |
| completed |
| Phase 3 |
| 210 |
| Memorial Sloan Kettering Cancer CenterOTHER |
| 1 |
| Oct 15, 2018 |
| clinicaltrials |
| NCT00606632 | Pre-surgical Detection of Clear Cell Renal Cell Carcinoma (ccRCC) Using Radiolabeled G250-Antibody | completed | Phase 3 | 226 | Heidelberg Pharma AGINDUSTRY | 1 | Oct 2, 2018 | clinicaltrials |
| NCT02086734 | Perfusion CT as a Predictor for Response to Antiangiogenic Therapy in Patients With Metastasized Renal Cell Carcinoma | completed | — | 60 | Ludwig-Maximilians - University of MunichOTHER | 1 | Oct 2, 2018 | clinicaltrials |
| NCT00375674 | A Clinical Trial Comparing Efficacy And Safety Of Sunitinib Versus Placebo For TheTreatment Of Patients At High Risk Of Recurrent Renal Cell Cancer(S-TRAC) | completed | Phase 3 | 674 | PfizerINDUSTRY | 22 | Sep 21, 2018 | clinicaltrials |
| NCT01158222 | Sunitinib Malate in Treating Patients With Previously Untreated Metastatic Kidney Cancer | completed | Phase 2 | 37 | Case Comprehensive Cancer CenterOTHER | 1 | Sep 14, 2018 | clinicaltrials |
| NCT03670992 | Surgical Treatment of Pancreatic RCC Metastases | completed | — | 26 | Azienda Policlinico Umberto IOTHER | 1 | Sep 14, 2018 | clinicaltrials |
| NCT01158521 | Pazopanib Hydrochloride Before Surgery in Treating Patients With Kidney Cancer | completed | Phase 2 | 25 | Case Comprehensive Cancer CenterOTHER | 1 | Sep 12, 2018 | clinicaltrials |
| NCT01625936 | CRLX101 Plus Bevacizumab in Advanced RCC | completed | Phase 1 | 22 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Aug 29, 2018 | clinicaltrials |
| NCT01727089 | Bevacizumab With or Without TRC105 in Treating Patients With Metastatic Kidney Cancer | completed | Phase 2 | 59 | National Cancer Institute (NCI)NIH | 3 | Aug 28, 2018 | clinicaltrials |
| NCT01154452 | Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma | completed | Phase 1 / Phase 2 | 78 | National Cancer Institute (NCI)NIH | 1 | Aug 15, 2018 | clinicaltrials |
| NCT02835833 | Study of Nintedanib Plus Bevacizumab in Advanced Solid Tumors | completed | Phase 1 | 21 | University of Alabama at BirminghamOTHER | 1 | Jul 10, 2018 | clinicaltrials |
| NCT00900276 | Biomarkers in Patients With Kidney Cancer or Cancer of the Urothelium and in Healthy Participants | completed | — | 5 | Wake Forest University Health SciencesOTHER | 1 | Jul 5, 2018 | clinicaltrials |
| NCT01553539 | Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery | completed | Phase 2 | 20 | Wake Forest University Health SciencesOTHER | 1 | Jul 5, 2018 | clinicaltrials |
| NCT01778933 | Intraoperative Imagery of Renal Nodules With Folate-fluorescein Conjugate(EC17) | completed | Early Phase 1 | 10 | University of PennsylvaniaOTHER | 1 | Jul 3, 2018 | clinicaltrials |
| NCT01950923 | Sildenafil Citrate Before Surgery in Improving Kidney Function in Patients With Kidney Cancer | completed | Phase 1 | 30 | Wake Forest University Health SciencesOTHER | 1 | Jul 3, 2018 | clinicaltrials |
| NCT02166255 | APN401 in Treating Patients With Melanoma, Kidney Cancer, Pancreatic Cancer, or Other Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery | completed | Phase 1 | 17 | Wake Forest University Health SciencesOTHER | 1 | Jul 3, 2018 | clinicaltrials |
| NCT03052504 | Prospective Versus Retrospective Complications in Radical Cystectomy and Nephrectomy | completed | — | 156 | Jørgen Bjerggaard JensenOTHER | 1 | Jun 27, 2018 | clinicaltrials |
| NCT00085436 | DC Vaccine Combined With IL-2 and IFNα-2a in Treating Patients With mRCC | completed | Phase 2 | 18 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Jun 26, 2018 | clinicaltrials |
| NCT00729053 | Study of IMO-2055 in Metastatic or Locally Recurrent Clear Cell Renal Carcinoma | completed | Phase 2 | 92 | Idera Pharmaceuticals, Inc.INDUSTRY | 1 | Jun 12, 2018 | clinicaltrials |
| NCT00790569 | Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking | completed | N/A | 315 | Butler HospitalOTHER | 1 | Jun 6, 2018 | clinicaltrials |
| NCT01411423 | Nexavar Post-marketing Surveillance for Renal Cell Carcinoma in Japan | completed | — | 3,305 | BayerINDUSTRY | 1 | Jun 6, 2018 | clinicaltrials |
| NCT01412671 | Nexavar Post-marketing Surveillance for RCC in Japan: Early Access Program | completed | — | 117 | BayerINDUSTRY | 1 | Jun 6, 2018 | clinicaltrials |
| NCT03013920 | CLE Characteristics of Upper Urinary Tract Urothelial Carcinoma | completed | — | 150 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Jun 6, 2018 | clinicaltrials |
| NCT01829841 | A Study of Famitinib in Patients With Advanced Metastatic Renal Cell Cancer | completed | Phase 2 | 150 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | May 3, 2018 | clinicaltrials |
| NCT02282579 | Spanish Retrospective Study to Evaluate the Efficacy and Safety of Targeted Therapies After Pazopanib as First-line Therapy(SPAZO) | completed | — | 300 | Spanish Oncology Genito-Urinary GroupOTHER | 1 | Apr 26, 2018 | clinicaltrials |
| NCT03091465 | Validation of the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) Prognostic Classification for Targeted Therapies (TKI/mTOR Inhibitors) in Second Line After First Line Treatment With Pazopanib(Spazo-2) | completed | — | 530 | Spanish Oncology Genito-Urinary GroupOTHER | 1 | Apr 26, 2018 | clinicaltrials |
| NCT00096629 | Vaccine Therapy in Treating Patients With Kidney Cancer | completed | Phase 1 | 15 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 25, 2018 | clinicaltrials |
| NCT00529802 | Exploratory Study Evaluating Fluorodeoxyglucose - Position Emission Tomography as a Predictive Marker for Therapy With RAD001 in Metastatic Renal Cell Cancer | completed | Phase 2 | 60 | University of ChicagoOTHER | 1 | Apr 25, 2018 | clinicaltrials |
| NCT01361113 | Neoadjuvant Pazopanib in Renal Cell Carcinoma | completed | Phase 2 | 21 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Apr 25, 2018 | clinicaltrials |
| NCT02216890 | Safety Study of SGN-CD70A in Cancer Patients | completed | Phase 1 | 38 | Seagen Inc.INDUSTRY | 1 | Apr 19, 2018 | clinicaltrials |
| NCT00923130 | Bevacizumab Plus Ixabepilone to Treat Patients With Advanced Kidney Cancer | completed | Phase 2 | 30 | National Cancer Institute (NCI)NIH | 1 | Apr 17, 2018 | clinicaltrials |
| NCT03471897 | Plasma Glycosaminoglycans as Diagnostic and Prognostic Biomarkers in Surgically Treated Renal Cell Carcinoma | completed | — | 237 | Chalmers University of TechnologyOTHER | 0 | Apr 17, 2018 | clinicaltrials |
| NCT01107509 | Pilot Study of Neo-Adjuvant Everolimus to Treat Advanced Renal Cell Carcinoma - Analysis of Biomarkers | completed | N/A | 20 | St. Joseph's Healthcare HamiltonOTHER | 1 | Apr 4, 2018 | clinicaltrials |
| NCT00448721 | A Phase II Trial of Perifosine Following Tyrosine Kinase Inhibitor (TKI) - Failure in Patients With Renal Cancer | completed | Phase 2 | 24 | AEterna ZentarisINDUSTRY | 1 | Mar 1, 2018 | clinicaltrials |
| NCT02075658 | A Comparative Study Between AirSeal, an Integrated Insufflation System, and Conventional Insufflation | completed | N/A | 60 | University of California, IrvineOTHER | 1 | Feb 14, 2018 | clinicaltrials |
| NCT01982097 | Sorafenib as Neoadjuvant Therapy Before Cytoreductive Nephrectomy in Patients With Metastatic Renal Cell Carcinoma(SANE) | completed | — | 61 | BayerINDUSTRY | 1 | Feb 7, 2018 | clinicaltrials |
| NCT00498966 | Ph II Study of Perifosine for Patients With Carcinoma of the Kidney | completed | Phase 2 | 50 | AEterna ZentarisINDUSTRY | 1 | Feb 5, 2018 | clinicaltrials |
| NCT00782275 | Avastin and Temsirolimus Following Tyrosine Kinase Inhibitor Failure in Patients With Advanced Renal Cell Carcinoma | completed | Phase 2 | 41 | Beth Israel Deaconess Medical CenterOTHER | 1 | Jan 24, 2018 | clinicaltrials |
| NCT01971905 | Perfusion Scanning's for Kidney Tumors | completed | — | 56 | Nessn AzawiOTHER | 1 | Jan 24, 2018 | clinicaltrials |
| NCT02295982 | Laparoscopic Versus Hand Assisted Laparoscopic Trans-peritoneal Laparoscopic Nephrectomy as One Day Surgery (i.e.: Are There Differences in Postoperative Outcome / Convalescence) | completed | N/A | 30 | Zealand University HospitalOTHER | 1 | Jan 24, 2018 | clinicaltrials |
| NCT01108445 | Phase II Study of Afinitor vs. Sutent in Patients With Metastatic Non-Clear Cell Renal Cell Carcinoma(ASPEN) | completed | Phase 2 | 131 | Duke UniversityOTHER | 3 | Jan 16, 2018 | clinicaltrials |
| NCT00726323 | A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC) | completed | Phase 2 | 74 | GlaxoSmithKlineINDUSTRY | 1 | Dec 11, 2017 | clinicaltrials |
| NCT00806650 | Anti-IMP3 Autoantibody and MicroRNA Signature Blood Tests in Finding Metastasis in Patients With Localized or Metastatic Kidney Cancer | completed | — | 155 | City of Hope Medical CenterOTHER | 1 | Dec 8, 2017 | clinicaltrials |
| NCT00622674 | Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 37 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Dec 2, 2017 | clinicaltrials |
| NCT00365287 | Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer | completed | Phase 1 / Phase 2 | 148 | Masonic Cancer Center, University of MinnesotaOTHER | 0 | Nov 29, 2017 | clinicaltrials |
| NCT00620295 | Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumors | completed | Phase 1 | 17 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Nov 29, 2017 | clinicaltrials |
| NCT00979329 | Study on the Influence of Sunitinib and Sorafenib on Fatigue, QoL, Depression in Patients With Metastatic RCC or GIST | completed | — | 100 | Radboud University Medical CenterOTHER | 1 | Nov 28, 2017 | clinicaltrials |
Data updated 23 days agoSource updated Oct 31, 2018source: clinicaltrials